{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:16:24Z","timestamp":1790050584888,"version":"4.0.1"},"reference-count":205,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00201","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T07:58:08Z","timestamp":1531209488000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":122,"title":["The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease"],"prefix":"10.3389","volume":"5","author":[{"given":"Kyle T.","family":"Amber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Valdebran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalaf","family":"Kridin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei A.","family":"Grando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2133.2005.06662.x","article-title":"Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland","volume":"153","author":"Gudi","year":"2005","journal-title":"Br J Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges."},{"key":"B4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaad.2014.02.030","article-title":"Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/bjd.13189","article-title":"Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital","volume":"171","author":"Forsti","year":"2014","journal-title":"Br J Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1111\/ijd.12492","article-title":"Incidence and mortality of bullous pemphigoid in north-east Poland (Podlaskie Province), 1999-2012: a retrospective bicentric cohort study","volume":"53","author":"Serwin","year":"2014","journal-title":"Int J Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2017","journal-title":"Clin Rev Allergy Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12026-017-8975-2","article-title":"Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/s0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort","volume":"167","author":"della","year":"2012","journal-title":"Br J Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","article-title":"Bullous pemphigoid: from the clinic to the bench","volume":"30","author":"Di","year":"2012","journal-title":"Clin Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamadermatol.2013.756","article-title":"Bullous pemphigoid as pruritus in the elderly: a common presentation","volume":"149","author":"Bakker","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/bjd.12936","article-title":"BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?","volume":"171","author":"Schmidt","year":"2014","journal-title":"Br J Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/jdv.12366","article-title":"Drug-induced pemphigoid: a review of the literature","volume":"28","author":"Stavropoulos","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/ced.13172","article-title":"Vesiculobullous eruption in a patient receiving psoralen ultraviolet A (PUVA) treatment for prurigo nodules: a case of PUVA-aggravated pemphigoid nodularis","volume":"42","author":"Amber","year":"2017","journal-title":"Clin Exp Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/ddg.13411","article-title":"Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma","volume":"16","author":"Amber","year":"2018","journal-title":"J Dtsch Dermatol Ges."},{"key":"B20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/ijd.13984","article-title":"A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors","volume":"57","author":"Lopez","year":"2018","journal-title":"Int J Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/1346-8138.14245","article-title":"Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid","volume":"45","author":"Chijiwa","year":"2018","journal-title":"J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/bjd.16479","article-title":"Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors","volume":"178","author":"Horikawa","year":"2018","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0190-9622(83)70036-8","article-title":"Eosinophilic spongiosis: a clinicopathologic review of seventy-one cases","volume":"8","author":"Crotty","year":"1983","journal-title":"J Am Acad Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/archderm.1984.01650450048015","article-title":"Eosinophilic spongiosis in bullous pemphigoid","volume":"120","author":"Nishioka","year":"1984","journal-title":"Arch Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0190-9622(87)80227-X","article-title":"Blood eosinophilia as a severity marker for bullous pemphigoid","volume":"16","author":"Bernard","year":"1987","journal-title":"J Am Acad Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/1744666x.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van","year":"2016","journal-title":"Expert Rev Clin Immunol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16679","article-title":"Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation","author":"Kridin","year":"2018","journal-title":"Br J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1582-4934.2007.00033.x","article-title":"Immunopathology and molecular diagnosis of autoimmune bullous diseases","volume":"11","author":"Mihai","year":"2007","journal-title":"J Cell Mol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","article-title":"In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases","volume":"78","author":"Moriuchi","year":"2015","journal-title":"J Dermatol Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5021\/ad.2012.24.1.45","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid","volume":"24","author":"Lee","year":"2012","journal-title":"Ann Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4103\/0378-6323.102364","article-title":"Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid","volume":"78","author":"Yang","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000381143","article-title":"Positive direct immunofluorescence is of better value than ELISA-BP180 and ELISA-BP230 values for the prediction of relapse after treatment cessation in bullous pemphigoid: a retrospective study of 97 patients","volume":"231","author":"Ingen-Housz-Oro","year":"2015","journal-title":"Dermatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00403-016-1631-1","article-title":"Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience","volume":"308","author":"Keller","year":"2016","journal-title":"Arch Dermatol Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Bagci","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 is critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1523-1747.2000.00141.x","article-title":"Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes","volume":"115","author":"Schmidt","year":"2000","journal-title":"J Invest Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1600-0625.2012.01529.x","article-title":"Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8","volume":"21","author":"Van","year":"2012","journal-title":"Exp Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.jid.2018.01.005","article-title":"Intravenous IgG reduces pathogenic autoantibodies, serum IL-6 levels, and disease severity in experimental bullous pemphigoid models","volume":"138","author":"Sasaoka","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.clim.2011.10.002","article-title":"Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model","volume":"142","author":"Ujiie","year":"2012","journal-title":"Clin Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1172\/jci3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"Budinger","year":"1998","journal-title":"J Clin Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1172\/jci28547","article-title":"T cell control in autoimmune bullous skin disorders","volume":"116","author":"Hertl","year":"2006","journal-title":"J Clin Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/tan.12960","article-title":"A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?","volume":"89","author":"Amber","year":"2017","journal-title":"Hla"},{"key":"B50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","article-title":"Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients","volume":"147","author":"Charneux","year":"2011","journal-title":"Arch Dermatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Blocker","year":"2012","journal-title":"Br J Dermatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1684\/ejd.2015.2719","article-title":"Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins","volume":"26","author":"Hayakawa","year":"2016","journal-title":"Eur J Dermatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/exd.13416","article-title":"Eosinophils as putative therapeutic targets in bullous pemphigoid","volume":"26","author":"Simon","year":"2017","journal-title":"Exp Dermatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1038\/s41598-017-04687-5","article-title":"Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome","volume":"7","author":"Giusti","year":"2017","journal-title":"Sci Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1465-9921-12-10","article-title":"Analysing the eosinophil cationic protein\u2013a clue to the function of the eosinophil granulocyte","volume":"12","author":"Bystrom","year":"2011","journal-title":"Respir Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12016-015-8485-8","article-title":"Eosinophilic skin diseases: a comprehensive review","volume":"50","author":"Long","year":"2016","journal-title":"Clin Rev Allergy Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/321613a0","article-title":"Mechanism of membrane damage mediated by human eosinophil cationic protein","volume":"321","author":"Young","year":"1986","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1067\/mai.2002.121460","article-title":"T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma","volume":"109","author":"Trautmann","year":"2002","journal-title":"J Allergy Clin Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2121-11-6","article-title":"TNF-alpha mediates eosinophil cationic protein-induced apoptosis in BEAS-2B cells","volume":"11","author":"Chang","year":"2010","journal-title":"BMC Cell Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneuroim.2010.06.012","article-title":"Eosinophil-induced neurotoxicity: the role of eosinophil cationic protein\/RNase 3","volume":"227","author":"Navarro","year":"2010","journal-title":"J Neuroimmunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000337752","article-title":"Eosinophil granular proteins damage bronchial epithelial cells infected with respiratory syncytial virus","volume":"158","author":"Kato","year":"2012","journal-title":"Int Arch Allergy Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.seminhematol.2012.01.005","article-title":"Eosinophils and disease pathogenesis","volume":"49","author":"Akuthota","year":"2012","journal-title":"Semin Hematol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.4049\/jimmunol.163.11.6321","article-title":"Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics","volume":"163","author":"Ying","year":"1999","journal-title":"J Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","article-title":"Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity","volume":"5","author":"Davoine","year":"2014","journal-title":"Front Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0190-9622(93)70170-X","article-title":"Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris","volume":"29","author":"Czech","year":"1993","journal-title":"J Am Acad Dermatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-4362.1995.tb01562.x","article-title":"Serum eosinophil cationic protein (ECP) in bullous pemphigoid","volume":"34","author":"Caproni","year":"1995","journal-title":"Int J Dermatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s004030050272","article-title":"IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity","volume":"290","author":"D'Auria","year":"1998","journal-title":"Arch Dermatol Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2249.2004.02570.x","article-title":"Interleukin-16 expression and release in bullous pemphigoid","volume":"137","author":"Frezzolini","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/jdv.12464","article-title":"Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid","volume":"29","author":"Tedeschi","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/exd.13382","article-title":"Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid","volume":"26","author":"Bieber","year":"2017","journal-title":"Exp Dermatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/BF00372588","article-title":"Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid","volume":"284","author":"Endo","year":"1992","journal-title":"Arch Dermatol Res."},{"key":"B73","first-page":"897","article-title":"Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid","volume":"148","author":"Borrego","year":"1996","journal-title":"Am J Pathol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0923-1811(97)00044-3","article-title":"Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid","volume":"16","author":"Inaoki","year":"1998","journal-title":"J Dermatol Sci."},{"key":"B75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/205873929901200202","article-title":"A Th2-like cytokine response is involved in bullous pemphigoid","volume":"12","author":"Feliciani","year":"1999","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/000155500750012162","article-title":"Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid","volume":"80","author":"Shrikhande","year":"2000","journal-title":"Acta Derm Venereol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1365-2133.2000.03599.x","article-title":"Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia","volume":"143","author":"Wakugawa","year":"2000","journal-title":"Br J Dermatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1006\/cyto.2000.0791","article-title":"Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils","volume":"13","author":"Engineer","year":"2001","journal-title":"Cytokine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.clim.2006.03.014","article-title":"Increased expression of Th2-associated chemokines in bullous pemphigoid disease","volume":"120","author":"Gounni","year":"2006","journal-title":"Clin Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/1346-8138.13435","article-title":"Combination therapy of prednisolone and iv immunoglobulin treatment decreases circulating interleukin-5 and eosinophils in a patient with bullous pemphigoid","volume":"44","author":"Yamashita","year":"2017","journal-title":"J Dermatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2340\/00015555-2581","article-title":"Increased activity and apoptosis of eosinophils in blister fluids, skin and peripheral blood of patients with bullous pemphigoid","volume":"97","author":"Engmann","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B82","first-page":"189","article-title":"Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts","volume":"33","author":"Bowszyc-Dmochowska","year":"2002","journal-title":"J Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1046\/j.0022-202x.2001.01521.x","article-title":"Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid","volume":"117","author":"Verraes","year":"2001","journal-title":"J Invest Dermatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cyto.2012.01.009","article-title":"Potent synergistic effect of IL-3 and TNF on matrix metalloproteinase 9 generation by human eosinophils","volume":"58","author":"Kelly","year":"2012","journal-title":"Cytokine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbrc.2004.01.078","article-title":"p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils","volume":"315","author":"Wiehler","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1172\/jci117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen","volume":"93","author":"Stahle-Backdahl","year":"1994","journal-title":"J Clin Invest."},{"key":"B87","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1165\/ajrcmb.17.4.2877","article-title":"Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9","volume":"17","author":"Okada","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1172\/jci3693","article-title":"A critical role for neutrophil elastase in experimental bullous pemphigoid","volume":"105","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"B89","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1346-8138.1992.tb03224.x","article-title":"Eosinophil phenotypes in bullous pemphigoid","volume":"19","author":"Tsuda","year":"1992","journal-title":"J Dermatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2133.1980.tb01683.x","article-title":"Cellular events leading to blister formation in bullous pemphigoid","volume":"103","author":"Dubertret","year":"1980","journal-title":"Br J Dermatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1346-8138.1992.tb03247.x","article-title":"Ultrastructural aspects of infiltrated eosinophils in bullous pemphigoid","volume":"19","author":"Iryo","year":"1992","journal-title":"J Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/1523-1747.ep12505711","article-title":"Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient","volume":"78","author":"Dvorak","year":"1982","journal-title":"J Invest Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archderm.1989.01670200055008","article-title":"Evidence for eosinophil degranulation in the pathogenesis of herpes gestationis","volume":"125","author":"Scheman","year":"1989","journal-title":"Arch Dermatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaci.2003.08.028","article-title":"Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization","volume":"112","author":"Davis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/BF00412972","article-title":"Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid","volume":"281","author":"Miyasato","year":"1989","journal-title":"Arch Dermatol Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"A615","DOI":"10.1016\/j.jid.2017.02.637","article-title":"Eosinophil major basic protein has a concentration-dependent cytotoxic effect on cultured keratinocytes","volume":"5","author":"Amber","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2133.2008.08880.x","article-title":"Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications","volume":"160","author":"Marzano","year":"2009","journal-title":"Br J Dermatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.prrv.2016.03.007","article-title":"Neutrophil extracellular traps in respiratory disease: guided anti-microbial traps or toxic webs?","volume":"21","author":"Cortjens","year":"2017","journal-title":"Paediatr Respir Rev"},{"key":"B99","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jaci.2010.11.002","article-title":"Eosinophil extracellular DNA traps in skin diseases","volume":"127","author":"Simon","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils mediate tissue injury in autoimmune skin disease bullous pemphigoid","volume":"138","author":"Lin","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1146\/annurev.immunol.17.1.931","article-title":"The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology","volume":"17","author":"Kinet","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e107725","DOI":"10.1371\/journal.pone.0107725","article-title":"Human eosinophils express the high affinity IgE receptor, FcepsilonRI, in bullous pemphigoid","volume":"9","author":"Messingham","year":"2014","journal-title":"PLoS ONE"},{"key":"B104","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3892\/ijmm.7.3.249","article-title":"Activation of Fc epsilon RI-positive eosinophils in bullous pemphigoid","volume":"7","author":"Kasahara-Imamura","year":"2001","journal-title":"Int J Mol Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archderm.1974.01630090016003","article-title":"IgE levels in sera of patients with pemphigus or bullous pemphigoid","volume":"110","author":"Arbesman","year":"1974","journal-title":"Arch Dermatol"},{"key":"B106","first-page":"193","article-title":"Immunopathology of bullous pemphigoid","volume":"18","author":"Provost","year":"1974","journal-title":"Clin Exp Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S0190-9622(83)70073-3","article-title":"Bullous pemphigoid: a cause of peripheral blood eosinophilia","volume":"8","author":"Bushkell","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/bjd.12161","article-title":"Detection of IgG and IgE reactivity to BP180 using the ISAC(R) microarray system","volume":"168","author":"Pomponi","year":"2013","journal-title":"Br J Dermatol"},{"key":"B109","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.157.8.3642","article-title":"IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid","volume":"157","author":"Delaporte","year":"1996","journal-title":"J Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1023\/A:1020531005776","article-title":"IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)","volume":"18","author":"Ghohestani","year":"1998","journal-title":"J Clin Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1067\/mjd.2000.103986","article-title":"IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity","volume":"42","author":"Dopp","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2133.2008.08858.x","article-title":"IgE autoantibodies against the intracellular domain of BP180","volume":"160","author":"Dresow","year":"2009","journal-title":"Br J Dermatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/bjd.15924","article-title":"IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants","volume":"177","author":"Freire","year":"2017","journal-title":"Br J Dermatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2016","journal-title":"Br J Dermatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00403-017-1789-1","article-title":"IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review","volume":"310","author":"Saniklidou","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1365-2133.2011.10748.x","article-title":"Successful management of severe infant bullous pemphigoid with omalizumab","volume":"166","author":"Dufour","year":"2012","journal-title":"Br J Dermatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","article-title":"Omalizumab therapy for bullous pemphigoid","volume":"71","author":"Yu","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B119","first-page":"123","article-title":"Cytokines and bullous pemphigoid","volume":"10","author":"D'Auria","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"B120","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0923-1811(02)00067-1","article-title":"Th1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid","volume":"30","author":"Giomi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1365-2133.2006.07601.x","article-title":"Serum chemokine profile in patients with bullous pemphigoid","volume":"156","author":"Nakashima","year":"2007","journal-title":"Br J Dermatol."},{"key":"B122","first-page":"27","article-title":"Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid","volume":"12","author":"Frezzolini","year":"2002","journal-title":"Eur J Dermatol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/all.13140","article-title":"Differences in eosinophil molecular profiles between children and adults with eosinophilic esophagitis","volume":"72","author":"Lingblom","year":"2017"},{"key":"B124","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.4049\/jimmunol.0801581","article-title":"Common gamma-chain-dependent signals confer selective survival of eosinophils in the murine small intestine","volume":"183","author":"Carlens","year":"2009","journal-title":"J Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.4049\/jimmunol.1101008","article-title":"SIRPalpha\/CD172a regulates eosinophil homeostasis","volume":"187","author":"Verjan","year":"2011","journal-title":"J Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/jid.2014.443","article-title":"Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice","volume":"135","author":"Hurskainen","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jaci.2017.12.1002","article-title":"New mechanism underlying IL-31-induced atopic dermatitis","volume":"141","author":"Meng","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.1038\/s41598-018-25094-4","article-title":"IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity","volume":"8","author":"Takamori","year":"2018","journal-title":"Sci Rep."},{"key":"B130","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","article-title":"The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves","volume":"138","author":"Feld","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jdermsci.2017.04.008","article-title":"Serum levels and tissue expression of interleukin-31 in dermatitis herpetiformis and bullous pemphigoid","volume":"87","author":"Bonciani","year":"2017","journal-title":"J Dermatol Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jdermsci.2017.07.019","article-title":"Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE","volume":"87","author":"Salz","year":"2017","journal-title":"J Dermatol Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/jid.2015.106","article-title":"IL-31 induces chemotaxis, calcium mobilization, release of reactive oxygen species, and CCL26 in eosinophils, which are capable to release IL-31","volume":"135","author":"Kunsleben","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2951","article-title":"Eosinophils are a major source of interleukin-31 in bullous pemphigoid","author":"Rudrich","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"B135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2340\/00015555662328","article-title":"Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease","volume":"66","author":"Wallengren","year":"1986","journal-title":"Acta Derm Venereol."},{"key":"B136","first-page":"31","article-title":"Expression of selected neuropeptides in pathogenesis of bullous pemphigoid and dermatitis herpetiformis","volume":"63","author":"Cynkier","year":"2012","journal-title":"Pol J Pathol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/sj.jid.5701079","article-title":"Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice","volume":"128","author":"Pavlovic","year":"2008","journal-title":"J Invest Dermatol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1398-9995.1995.tb02509.x","article-title":"Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis","volume":"50","author":"Fajac","year":"1995","journal-title":"Allergy"},{"key":"B139","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/exd.12717","article-title":"Substance P activates human eosinophils","volume":"24","author":"Raap","year":"2015","journal-title":"Exp Dermatol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/exd.12806","article-title":"Substance P and eosinophils: an itchy connection","volume":"24","author":"Friedman","year":"2015","journal-title":"Exp Dermatol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"e22029","DOI":"10.1371\/journal.pone.0022029","article-title":"Eosinophils increase neuron branching in human and murine skin and >in vitro","volume":"6","author":"Foster","year":"2011","journal-title":"PLoS ONE"},{"key":"B142","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jaci.2014.07.003","article-title":"Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice","volume":"135","author":"Lee","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"L326","DOI":"10.1152\/ajplung.00254.2004","article-title":"Mechanism of eosinophil induced signaling in cholinergic IMR-32 cells","volume":"288","author":"Curran","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s004030000142","article-title":"Eosinophil cationic protein- and eosinophil-derived neurotoxin\/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis","volume":"292","author":"Johansson","year":"2000","journal-title":"Arch Dermatol Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1165\/rcmb.2003-0188OC","article-title":"Effect of eosinophil adhesion on intracellular signaling in cholinergic nerve cells","volume":"30","author":"Walsh","year":"2004","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"L915","DOI":"10.1152\/ajplung.00094.2003","article-title":"Effects of eosinophils on nerve cell morphology and development: the role of reactive oxygen species and p38 MAP kinase","volume":"285","author":"Kingham","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1165\/rcmb.2005-0056OC","article-title":"Diverse effects of eosinophil cationic granule proteins on IMR-32 nerve cell signaling and survival","volume":"33","author":"Morgan","year":"2005","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molimm.2014.05.014","article-title":"Eosinophil peroxidase induces expression of cholinergic genes via cell surface neural interactions","volume":"62","author":"Akasheh","year":"2014","journal-title":"Mol Immunol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1165\/rcmb.2005-0196OC","article-title":"Eosinophil-mediated cholinergic nerve remodeling","volume":"34","author":"Durcan","year":"2006","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00004397-198602640-00012","article-title":"Dermatological diseases and the peripheral cornea","volume":"26","author":"Mondino","year":"1986","journal-title":"Int Ophthalmol Clin."},{"key":"B151","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.4049\/jimmunol.173.10.5963","article-title":"Eosinophil adhesion to cholinergic IMR-32 cells protects against induced neuronal apoptosis","volume":"173","author":"Morgan","year":"2004","journal-title":"J Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1172\/jci117594","article-title":"Cationic protein-induced sensory nerve activation: role of substance P in airway hyperresponsiveness and plasma protein extravasation","volume":"94","author":"Coyle","year":"1994","journal-title":"J Clin Invest."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1152\/jappl.2001.91.3.1318","article-title":"Effects of human eosinophil granule-derived cationic proteins on C-fiber afferents in the rat lung","volume":"91","author":"Lee","year":"2001","journal-title":"J Appl Physiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"L544","DOI":"10.1152\/ajplung.00271.2007","article-title":"Sensitization of isolated rat vagal pulmonary sensory neurons by eosinophil-derived cationic proteins","volume":"294","author":"Gu","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"L453","DOI":"10.1152\/ajplung.90467.2008","article-title":"Mechanisms of eosinophil major basic protein-induced hyperexcitability of vagal pulmonary chemosensitive neurons","volume":"296","author":"Gu","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000236548","article-title":"Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo","volume":"102","author":"Dvorak","year":"1993","journal-title":"Int Arch Allergy Immunol."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1997.273.1.L93","article-title":"Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function","author":"Costello","year":"1997","journal-title":"Am J Physiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1189\/jlb.0906548","article-title":"Modulation of eosinophil activation in vitro by a nicotinic receptor agonist","volume":"81","author":"Blanchet","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/imm.12885","article-title":"Resident intestinal eosinophils constitutively express antigen presentation markers and include two phenotypically distinct subsets of eosinophils","volume":"154","author":"Xenakis","year":"2017","journal-title":"Immunology"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1073\/pnas.86.4.1348","article-title":"Mature human eosinophils have the capacity to express HLA-DR","volume":"86","author":"Lucey","year":"1989","journal-title":"Proc Natl Acad Sci USA."},{"key":"B161","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/jci8945","article-title":"Lymph node trafficking and antigen presentation by endobronchial eosinophils","volume":"105","author":"Shi","year":"2000","journal-title":"J Clin Invest."},{"key":"B162","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.4049\/jimmunol.179.11.7585","article-title":"Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells","volume":"179","author":"Wang","year":"2007","journal-title":"J Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3389\/fimmu.2017.01781","article-title":"Granulocytes: new members of the antigen-presenting cell family","volume":"8","author":"Lin","year":"2017","journal-title":"Front Immunol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MPG.0b013e3182758d49","article-title":"Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis","volume":"56","author":"Le-Carlson","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1172\/jci116331","article-title":"Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor","volume":"91","author":"Jacoby","year":"1993","journal-title":"J Clin Invest."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1084\/jem.157.6.1981","article-title":"Activation of basophil and mast cell histamine release by eosinophil granule major basic protein","volume":"157","author":"O'Donnell","year":"1983","journal-title":"J Exp Med."},{"key":"B167","first-page":"611","article-title":"Pharmacological control of human basophil histamine release stimulated by eosinophil granule major basic protein","volume":"66","author":"Thomas","year":"1989","journal-title":"Immunology"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/nejm199805283382206","article-title":"Eosinophilia","volume":"338","author":"Rothenberg","year":"1998","journal-title":"N Engl J Med"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de","year":"2017","journal-title":"Allergy"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e31066","DOI":"10.1371\/journal.pone.0031066","article-title":"The flavonoid luteolin inhibits Fcgamma-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice","volume":"7","author":"Oswald","year":"2012","journal-title":"PLoS ONE"},{"key":"B171","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ni.1981","article-title":"Eosinophils are required for the maintenance of plasma cells in the bone marrow","volume":"12","author":"Chu","year":"2011","journal-title":"Nat Immunol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/eji.201141953","article-title":"Immunization induces activation of bone marrow eosinophils required for plasma cell survival","volume":"42","author":"Chu","year":"2012","journal-title":"Eur J Immunol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd1982","article-title":"An APRIL to remember: novel TNF ligands as therapeutic targets","volume":"5","author":"Dillon","year":"2006","journal-title":"Nat Rev Drug Discov."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/intimm\/7.7.1093","article-title":"BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes","volume":"7","author":"Gras","year":"1995","journal-title":"Int Immunol."},{"key":"B176","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1126\/science.278.5335.138","article-title":"NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily","volume":"278","author":"von","year":"1997","journal-title":"Science"},{"key":"B177","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O'Connor","year":"2004","journal-title":"J Exp Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.4049\/jimmunol.175.5.2814","article-title":"B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells","volume":"175","author":"Yang","year":"2005","journal-title":"J Immunol."},{"key":"B179","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","article-title":"BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator","volume":"285","author":"Moore","year":"1999","journal-title":"Science"},{"key":"B180","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2133.2006.07305.x","article-title":"Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris","volume":"155","author":"Asashima","year":"2006","journal-title":"Br J Dermatol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jdermsci.2006.12.008","article-title":"Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid","volume":"46","author":"Watanabe","year":"2007","journal-title":"J Dermatol Sci."},{"key":"B182","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/347669a0","article-title":"Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES","volume":"347","author":"Schall","year":"1990","journal-title":"Nature"},{"key":"B183","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.150.8.3442","article-title":"RANTES is a chemotactic and activating factor for human eosinophils","volume":"150","author":"Alam","year":"1993","journal-title":"J Immunol."},{"key":"B184","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.7569902","article-title":"Activation of dual T cell signaling pathways by the chemokine RANTES","volume":"269","author":"Bacon","year":"1995","journal-title":"Science"},{"key":"B185","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1084\/jem.176.2.587","article-title":"Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils","volume":"176","author":"Kameyoshi","year":"1992","journal-title":"J Exp Med."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1084\/jem.176.6.1489","article-title":"RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes","volume":"176","author":"Rot","year":"1992","journal-title":"J Exp Med."},{"key":"B187","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4049\/jimmunol.156.7.2566","article-title":"Human eosinophils elaborate the lymphocyte chemoattractants","volume":"156","author":"Lim","year":"1996","journal-title":"J Immunol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1189\/jlb.0108058","article-title":"Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially","volume":"85","author":"Spencer","year":"2009","journal-title":"J Leukoc Biol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.4049\/jimmunol.173.10.5909","article-title":"Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase","volume":"173","author":"Odemuyiwa","year":"2004","journal-title":"J Immunol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1128\/iai.00931-10","article-title":"Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice","volume":"79","author":"O'Connell","year":"2011","journal-title":"Infect Immun."},{"key":"B191","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/microbiolspec.MCHD-0020-2015","article-title":"The regulatory function of eosinophils","volume":"4","author":"Wen","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B192","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.8755-8920.2003.00118.x","article-title":"Tissue eosinophilia in pemphigoid gestationis: association with eotaxin and upregulated activation markers on transmigrated eosinophils","volume":"51","author":"Gunther","year":"2004","journal-title":"Am J Reprod Immunol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.1365-2249.2002.01755.x","article-title":"Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti","volume":"127","author":"Jean-Baptiste","year":"2002","journal-title":"Clin Exp Immunol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1046\/j.1365-2133.2000.03894.x","article-title":"High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid","volume":"143","author":"Sun","year":"2000","journal-title":"Br J Dermatol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1365-2249.2001.01503.x","article-title":"The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone","volume":"124","author":"Schmidt","year":"2001","journal-title":"Clin Exp Immunol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s12192-014-0513-8","article-title":"Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes","volume":"19","author":"Tukaj","year":"2014","journal-title":"Cell Stress Chaperones"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1183\/23120541.00003-2015","article-title":"Trans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral blood in vitro","volume":"1","author":"Nishihara","year":"2015","journal-title":"ERJ Open Res."},{"key":"B198","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/1043-4666(90)90045-U","article-title":"Cytokines in skin lesions of psoriasis","volume":"2","author":"Gearing","year":"1990","journal-title":"Cytokine"},{"key":"B199","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1523-1747.ep12556058","article-title":"Neutrophil-activating proteins in psoriasis","volume":"98","author":"Schroder","year":"1992","journal-title":"J Invest Dermatol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1165\/rcmb.2005-0303OC","article-title":"Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils","volume":"34","author":"Kikuchi","year":"2006","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0091-6749(93)90099-2","article-title":"Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes","volume":"92","author":"Bruijnzeel","year":"1993","journal-title":"J Allergy Clin Immunol."},{"key":"B202","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.4049\/jimmunol.161.6.3064","article-title":"Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator","volume":"161","author":"Liu","year":"1998","journal-title":"J Immunol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1165\/ajrcmb.16.4.9115757","article-title":"Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines","volume":"16","author":"Okada","year":"1997","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2249.2011.04464.x","article-title":"Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid","volume":"166","author":"Gunther","year":"2011","journal-title":"Clin Exp Immunol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0091-6749(03)01798-6","article-title":"Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge","volume":"112","author":"Liu","year":"2003","journal-title":"J Allergy Clin Immunol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T12:44:38Z","timestamp":1693745078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":205,"alternative-id":["10.3389\/fmed.2018.00201"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00201","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,10]]},"article-number":"201"}}